Study identifier:SP-ROA-0022
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A double-blind placebo controlled study comparing efficacy and tolerability of intra-articular saline, 7.5 mg/ml or 10 mg/ml ropivacaine following arthroscopic knee surgery.
unknown
N/A
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|